Dr. Ben Weston, Milwaukee COVID-19 Emergency Operations Center Medical Director, talks about the process of approving the COVID-19 vaccine for children and the global fight against COVID-19.
Novavax CEO Stanley Erck joins Yahoo Finance to discuss the company's filing for vaccine authorization in the UK, plans to seek approval from the FDA, and how supply chain disruption has affected the ramp-up of vaccine production.
Johnson & Johnson (NYSE: JNJ) recently reported its financial results for the third quarter of 2021. In this Motley Fool Live video recorded on Oct. 20, 2021, Motley Fool contributors Keith Speights and Brian Orelli talk about what investors especially liked about J&J's results. On Tuesday, yesterday, Johnson & Johnson announced its Q3 results.